Literature DB >> 864774

A comprehensive program for meeting psychosocial needs of sickle cell anemia patients.

J Vavasseur.   

Abstract

Some of the methods used at the Comprehensive Sickle Cell Center at Los Angeles County-University of Southern California Medical Center are explored. Additional methods must be tried and evaluated with appropriate documentation. A determination of the true effectiveness of the methods used is a major challenge and provides opportunity for further investigation. Certainly the tasks are myriad. Paraphrasing Dr. Marilyn Gaston, "Through effective coordination and communication by a multi-faceted team, improvement of the quality of life with a realistic outlook for the future can be achieved."(1)

Entities:  

Mesh:

Year:  1977        PMID: 864774      PMCID: PMC2536973     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  3 in total

1.  Natural history of sickle cell disease--the first ten years.

Authors:  D R Powars
Journal:  Semin Hematol       Date:  1975-07       Impact factor: 3.851

2.  Sickle cell disease: meeting a need.

Authors:  D E Jackson
Journal:  Nurs Clin North Am       Date:  1972-12       Impact factor: 1.208

3.  Psychosocial effects of sickle cell disease.

Authors:  C F Whitten; J Fischhoff
Journal:  Arch Intern Med       Date:  1974-04
  3 in total
  2 in total

Review 1.  A brief review of the pathophysiology, associated pain, and psychosocial issues in sickle cell disease.

Authors:  Christopher L Edwards; Mischca T Scales; Charles Loughlin; Gary G Bennett; Shani Harris-Peterson; Laura M De Castro; Elaine Whitworth; Mary Abrams; Miriam Feliu; Stephanie Johnson; Mary Wood; Ojinga Harrison; Alvin Killough
Journal:  Int J Behav Med       Date:  2005

2.  Disease management, coping, and functional disability in pediatric sickle cell disease.

Authors:  Gloria Oliver-Carpenter; Ilana Barach; Lori E Crosby; Jessica Valenzuela; Monica J Mitchell
Journal:  J Natl Med Assoc       Date:  2011-02       Impact factor: 1.798

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.